These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22224940)

  • 21. Advances in management of sickle cell disease.
    Agarwal MB
    Indian J Pediatr; 2003 Aug; 70(8):649-54. PubMed ID: 14510086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle cell anaemia: current therapies.
    Vermylen C
    Transfus Apher Sci; 2013 Oct; 49(2):151-4. PubMed ID: 23954416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Chaturvedi S; DeBaun MR
    Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era.
    Kwiatkowski JL; Voeks JH; Kanter J; Fullerton HJ; Debenham E; Brown L; Adams RJ;
    Am J Hematol; 2019 Dec; 94(12):1335-1343. PubMed ID: 31489983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normalized transcranial Doppler velocities, stroke prevention and improved pulmonary function after stem cell transplantation in children with sickle cell anemia.
    Mynarek M; Bettoni da Cunha Riehm C; Brinkmann F; Weißenborn K; Tell-Lüersen M; Heuft HG; Maecker-Kolhoff B; Sykora KW
    Klin Padiatr; 2013 May; 225(3):127-32. PubMed ID: 23625683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurologic and Cognitive Outcomes in Sickle Cell Disease from Infancy through Adolescence.
    Mayer SL; Fields ME; Hulbert ML
    Neoreviews; 2021 Aug; 22(8):e531-e539. PubMed ID: 34341160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic cell transplantation: a curative option for sickle cell disease.
    Krishnamurti L
    Pediatr Hematol Oncol; 2007 Dec; 24(8):569-75. PubMed ID: 18092247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
    Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
    Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of hydroxyurea in prevention of stroke in children with sickle cell disease.
    Lefèvre N; Dufour D; Gulbis B; Lê PQ; Heijmans C; Ferster A
    Blood; 2008 Jan; 111(2):963-4; author reply 964. PubMed ID: 18182580
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.
    Abdullahi SU; Wudil BJ; Bello-Manga H; Musa AB; Gambo S; Galadanci NA; Aminu H; Tijjani Gaya A; Sanusi S; Tabari MA; Galadanci A; Borodo A; Abba MS; Dambatta AH; Haliru L; Gambo A; Cassell H; Rodeghier M; Ghafuri DL; Covert Greene BV; Neville K; Kassim AA; Kirkham F; Trevathan E; Jordan LC; Aliyu MH; DeBaun MR
    Pediatr Hematol Oncol; 2021 Feb; 38(1):49-64. PubMed ID: 33236662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
    Lagunju I; Brown BJ; Oyinlade AO; Asinobi A; Ibeh J; Esione A; Sodeinde OO
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27252. PubMed ID: 29797633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the role of hydroxyurea in children with sickle cell disease.
    Rogers ZR; Buchanan GR
    J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174
    [No Abstract]   [Full Text] [Related]  

  • 35. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).
    Ware RE; Helms RW;
    Blood; 2012 Apr; 119(17):3925-32. PubMed ID: 22318199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.
    DeBaun MR
    J Pediatr; 2005 Oct; 147(4):560-1. PubMed ID: 16227052
    [No Abstract]   [Full Text] [Related]  

  • 37. Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa.
    Smart LR; Ambrose EE; Balyorugulu G; Songoro P; Shabani I; Komba P; Charles M; Howard TA; McElhinney KE; O'Hara SM; Odame J; Nakafeero M; Adams J; Stuber SE; Lane A; Latham TS; Makubi AN; Ware RE
    Acta Haematol; 2023; 146(2):95-105. PubMed ID: 35977532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of hydroxyurea to prevent silent stroke in sickle cell disease: Systematic review and meta-analysis.
    Hasson C; Veling L; Rico J; Mhaskar R
    Medicine (Baltimore); 2019 Dec; 98(51):e18225. PubMed ID: 31860969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevention and management of stroke in sickle cell anaemia.
    Qureshi N; Lubin B; Walters MC
    Expert Opin Biol Ther; 2006 Nov; 6(11):1087-98. PubMed ID: 17049007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
    Mack AK; Thompson AA
    J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.